Effects of acute caffeine administration on NOS and Bax/Bcl2 expression in the myocardium of rat

Pharmacological Research

Volumn 57, Issue 1, 2008, Pages 19-25

  Corsetti, Giovanni ^a   Pasini, Evasio ^b   Assanelli, Deodato ^a   Bianchi, Rossella ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Apoptosis; Caffeine; Hemodynamic; Myocardium; Nitric oxide; Rat

Indexed keywords

ARGININE; CAFFEINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; HEART HEMODYNAMICS; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PRESSURE; CAFFEINE; HEART; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 39149092059     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.07.007     Document Type: Article

References (46)

1. World Heath Organization. Coffee, tea, mate, methylxantines and methylglyoxal, IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 27 February to 6 March 1990, IARC Monogr. Eval. Carcinog. Risks Hum. 1991;51:1-513.
2. Daly J.W. Mechanism of action of caffeine. In: Garattini S. (Ed). Caffeine, coffee, and health (1993), Raven Press Ltd., New York 97-150
3. Birnbaum L.J., and Herbst J.D. Physiologic effects of caffeine on cross-country runners. J Strength Cond Res 18 3 (2004) 463-465
4. McLellan T.M., Bell D.G., and Kamimori G.H. Caffeine improves physical performance during 24 h of active weakfulness. Aviat Space Environ Med 75 (2004) 666-672
5. O'Connor P.J., Motl R.W., Broglio S.P., and Ely M.R. Dose-dependent effect of caffeine on reducing leg muscle pain during cycling exercise is unrelated to systolic blood pressure. Pain 109 (2004) 291-298
6. Doherty M., and Smith P.M. Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta-analysis. Scand J Med Sci Sports 15 2 (2005) 69-78
7. Kayir H., and Uzbay I.T. Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. Psychopharmacology 172 1 (2004) 11-15
8. Papaioannou T.G., Karatzi K., Karatzis E., Papamichael C., and Lekakis J.P. Acute effects of caffeine on arterial stiffness, wave reflections, and central aortic pressure. Am J Hypertens 18 (2005) 129-136
9. Davis J.M., Zhao Z., Stock H.S., Mehl K.A., Buggy J., and Hand G.A. Central nervous system effects of caffeine and adenosine on fatigue. Am J Physiol Regul Integr Comp Physiol 284 (2003) R399-R404
10. Kalmar J.M. The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc 37 (2005) 2113-2119
11. Nurminen M.L., Niittynen L., Korpela R., and Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr 53 (1999) 831-839
12. Savoca M.R., Evans C.D., Wilson M.E., Harshfield G.A., and Ludwig D.A. The association of caffeinated beverages with blood pressure in adolescents. Arch Pediatr Adolesc Med 158 (2004) 473-477
13. Bruce C., Yates D.H., and Thomas P.S. Caffeine decreases exaled nitric oxide. Thorax 57 (2002) 361-363
14. Bredt D.S., and Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron 8 (1992) 3-11
15. Pollock J.S., Forstermann U., Tracey W.R., and Nakane M. Nitric oxide synthase isozyme antibodies. Histochem J 27 (1995) 738-744
16. Hare J.M., and Stamler J.S. NOS: modulator, not mediator of cardiac performance. Nat Med 5 (1999) 273-274
17. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxideregulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 (2002) 337-339
18. Stamler J.S., and Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Res 81 (2001) 209-237
19. Balligand J.L., Ungureanu-Longrois D., Simmons W., Pimental D., Malinski T.A., Kapturczak M., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 269 (1994) 27580-27588
20. Garcia L., Martinou I., Tsujimoto Y., and Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258 (1992) 302-304
21. Allsopp T.E., Wyatt S., Paterson H.F., and Davies A.M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73 (1993) 295-307
22. Piñón L.G.P., Middleton G., and Davies A.M. Bcl-2 is required for cranial sensory neuron survival at defined stages of embryonic development. Development 124 (1997) 4173-4178
23. Chao D.T., and Korsmeyer S.J. BCL-2 family: regulators of cell death. Annu Rev Immunol 16 (1998) 395-419
24. Kunapuli S., Rosanio S., and Schwarz E.R. How do cardiomyocytes die? Apoptosis and autophagic cell death in cardiac myocytes. J Cardiac Failure 12 5 (2006) 381-391
25. Jafari M., and Rabbani A. Studies on the mechanism of caffeine action in alveolar macrophages: caffeine elevates cyclic adenosine monophosphate level and prostaglandin synthesis. Metabolism 53 6 (2004) 687-692
26. Corsetti G., Pasini E., Assanelli D., Saligari E., Adobati M., and Bianchi R. Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles. Pharmacol Res 55 (2007) 96-103
27. Fukuto J.M., and Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 35 (1995) 165-194
28. Pasini E., Solfrini R., Bachetti T., Marino M., Bernocchi P., Visioli F., et al. The blood perfusion isolated heart: characterisation of the model. Basic Res cardiol 94 (1999) 215-222
29. White P.J., and Nguyen T.T. Chronic caffeine treatment causes changes in cardiac adenosine receptor function in rats. Pharmacology 65 (2002) 129-135
30. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., and Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96 (1999) 657-662
31. Khan S.A., Skef M.W., Harrison R.W., Lee K., Minhas K.M., Kumar A., et al. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthase. Circ Res 92 (2003) 1322-1329
32. Trafford A.W., Sibbring G.C., Diaz M.E., and Eisner D.A. The effects of low concentration of caffeine on spontaneous Ca release in isolated rat ventricular myocytes. Cell Calcium 28 (2000) 269-276
33. Miethke A., Feussner M., Planitzer G., Richter H., Gutsmann M., and Gossrau R. Localisation of NOS-1 in the sarcolemma region of a sub-population of atrial cardiomyocytes including myoendocrine cells and NOS-3 in vascular and endocardial endothelial cells of the rat hearth. Acta Histochem 105 (2003) 43-55
34. Garcìa-Cardeňa G., Martasek P., Siler-Masters B.S., Skidd P.M., Couet J., Li S., et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. J Biol Chem 272 (1997) 25437-25440
35. 2+ release in cardiomyocytes. Nat Cell Biol 3 (2001) 867-873
36. Ziolo M.T., Dollinger S.J., and Wahler G.M. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine. J Mol Cell Cardiol 30 (1998) 1009-1017
37. Ziolo M.T., Katon H., and Bers D.M. Expression of inducible nitric oxide synthase depresses β-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104 (2001) 2961-2966
38. Jones S.P., and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40 1 (2006) 16-23
39. Bennet M.R. Apoptosis in the cardiovascular system. Heart 87 (2002) 480-487
40. Shimizu S, Narita M, Tsujimoto Y. Bcl2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487. Erratum in Nature 2000: 407: 767.
41. Bode A.M., and Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247 (2007) 26-39
42. Lelo A., Miners J.O., Robson R., and Birkett D.J. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin Pharmacol Ther 39 (1986) 54-59
43. Anversa P, Leri A, Rota M, Bearzi C, Urbanek K, Kajstura J, Bolli R. Stem cells, myocardial regeneration and methodological artifacts. Stem Cell 2006: Epub Nov. 30.
44. Vlachopoulos C., Hirata K., and O'Rourke M.F. Effect of caffeine on aortic elastic properties and wave reflection. J Hypertens 21 (2003) 563-570
45. Nyska A., Murphy E., Foley J.F., Collins B.J., Petranka J., Howden R., et al. Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicol Sci 83 (2005) 388-396
46. Freireich E.J., Gehan E.A., Rall D.P., Schmidt L.H., and Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemiother 50 (1966) 219-244